Covid-19 roundup: Ox­ford Bio­med­ica and As­traZeneca ex­tend vac­cine deal; FDA wants boost­ers for new­er vari­ants

An Ox­ford Uni­ver­si­ty spin­out and one of the ma­jor play­ers in the phar­ma in­dus­try are ex­tend­ing their col­lab­o­ra­tion on its Covid shot.

Ox­ford Bio­med­ica and As­traZeneca on Fri­day an­nounced that they have signed a new three-year agree­ment on fu­ture man­u­fac­tur­ing for the As­traZeneca Covid-19 vac­cine. Ac­cord­ing to Ox­ford Bio­med­ica, this deal is an ex­pan­sion of the orig­i­nal agree­ment an­nounced be­tween the two com­pa­nies dur­ing the first waves of the pan­dem­ic in Sep­tem­ber 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER